Latest Press Release on drugs

New Discount Drug Program Benefits the Growing Unemployed
MedSaverCard, a free program providing discounts on prescription drugs for people without health insurance, wants the growing number of unemployed workers to know they have options when it comes to buying prescription drugs./I/P P(PRWEB) November 23, 2009 -- MedSaverCard, a free program...

---

Cambridge-based Ligon Discovery Raises $1M in Seed Funding
CAMBRIDGE, Mass., Nov. 19 /PRNewswire/ -- Ligon Discovery, Inc., which uses proprietary small molecule microarray technology to find drugs against high-value targets, today announced that it has raised $1M in seed financing led by incTANK Ventures. The company will use the capital to co...

---

AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD / NIH International Conference
BOTHELL, WA -- 11/19/09 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced presentations on the company's exon skipping therapy for Duchenne muscular dystrophy at the TREAT-NMD / NIH International Conference taki..

---

Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA
BEIJING, Nov. 24 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical pr...

---

Single Mom Debuts a Spectacular True Story, No Happily Ever After But...
No Happily Ever After But... is an intriguing story of a woman's life who struggled with alcohol, drugs, anxiety and adversity to an amazing experience that led her to a one of a kind 'rose'. Never has there been a 'rose' like this before. Debbie Fellows never intended to write a book however...

---

Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman
CAMBRIDGE, Mass., Nov. 23 /PRNewswire/ -- Ligon Discovery, Inc., which uses proprietary small molecule microarray technology to find drugs against high-value targets, today announced the appointment of pharmaceutical industry veteran Errol B. De Souza as Ligon's Executive Chairman o...

---

Breaking the News, or Fueling the Epidemic? News Coverage of Opioid-Related Deaths Often Precede an Increase in Deaths, Study Finds
BOSTON, Nov. 18 /PRNewswire-USNewswire/ -- Increases in deaths from opioid drugs such as OxyContin may be linked to the volume of coverage such deaths receive in the news, according to a study from Children's Hospital Boston and the University of North Carolina (UNC), Chapel Hill. The s...

---

instaCare Corp. Continues Turnaround, Reports 58% Revenues Increase for First Three Quarters
LOS ANGELES, Nov. 18 -- instaCare Corp., (OTC Bulletin Board: ISCR), a leading distributor of life-saving prescription drugs and at-home testing diagnostics for the chronically ill, and a leading developer of patentable technologies for e-pharmacy, e-he...

---

Pfizer and DNDi Advancing International Research Efforts In The Fight Against Neglected Tropical Diseases
NEW YORK & GENEVA - Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vu

---

Rapid drugs of abuse screening from Randox
Randox have developed an innovative multi-marker drugs of abuse testing procedure for rapid drug screening programmes. The Drugs of Abuse (DoA) biochips permit the analysis of up to 10 drug classes from a single patient sample providing rapid and accurate testing.

---

DopeStats.com Provides Statistical Information on Legal and Illegal Drugs in Each U.S. County
Information about drug use and drug information is now just a click away with the recently launched DopeStats.com. The new site is an online statistical database documenting drug use in more than 3,000 counties in the United States. The data is compiled by anonymous users on drugs and herbs f...

---

Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090
LEXINGTON, Mass. - Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Mole

---

Synta Presents New Data on Mechanism of Action of Elesclomol at AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics
LEXINGTON, Mass. - Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today presented new data on the mechanism of action of elesclomol, a first-in-class oxid

---

Generic Drugs Just as Effective as Brand Name Drugs Says DoctorSolve
Despite years of controversy, new study finds that generic drugs to be equally as effective as brand name drugs./I/P P(PRWEB) November 19, 2009 -- A recent publication in the October issue of The Medical Letter may help to eliminate the fear many people have about generic drugs. A syste...

---

Latest Trend to Lose Weight: Nutritional Body Cleansing
Most of us are exposed to doctors, hospitals and taught to take prescription medication (drugs) to treat the symptoms of the life illnesses and weight loss. Through the use of natural a href= http://www.cleansingandnutrition.com/ onclick= linkClick( this.href ); target= _blank title= bo...

---

Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology
BALTIMORE, Nov. 18 -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclu...

---

AVI BioPharma, Inc. to Present at Transformational Medical Technologies Initiative (TMTI) Industry Day
BOTHELL, WA -- 11/18/09 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that Patrick Iversen, Ph.D., Senior Vice President of Strategic Alliances, will present at the upcoming Transformational Medical Technolo..

---

Find Product Liability Lawyers and Legal Information at LawyerCentral.com
(EMAILWIRE.COM, November 18, 2009 ) New York, NY - Lawyer Central has released an updated Product Liability Information Center featuring legal articles about Dangerous Drugs, Defective Medical Devices, and Products Liability Law. It is important for ..

---

Cardinus Supports Road Safety Week Focus on Drink and Drugs
Cardinus Risk Management is backing this year’s Road Safety Week, which is focusing on the theme of drinks and drugs, and endorsing the message from the organisers, road safety charity Brake, for companies to do more in getting the message across to staff about the dangers of driving un...

---

FDA Advisory Committee Finds Data Support the Claim That SPIRIVA® HandiHaler® Reduces COPD Exacerbations
RIDGEFIELD, Conn. & NEW YORK - The U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new drug application (sNDA) provide substantial and convincing evidence to support the claim that SPIRIVA

---